Characterization of the β‐adrenoceptor subtype involved in mediation of glucose transport in L6 cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The receptor that mediates the increase in glucose transport (GT) in response to β‐adrenoceptor (β‐AR) agonists was characterized in the rat skeletal muscle cell line L6, using the 2‐deoxy‐[3 H]‐D‐glucose assay. The β 3‐AR agonist BRL37344 (pEC 50=6.89±0.21), the β‐AR agonist isoprenaline (pEC 50=8.99±0.24) and the β 2‐AR agonist zinterol (pEC 50=9.74±0.15) increased GT as did insulin (pEC 50=6.93±0.15). The highly selective β 3‐AR agonist CL316243 only weakly stimulated GT. The pK B values calculated from the shift of the pEC 50 values of the agonists in the presence of the β 1‐AR selective antagonist CGP 20712A or the β 3‐AR selective antagonist SR 59230A were not indicative of activation of β 1‐ or β 3‐ARs. Only (−)‐propranolol and the β 2‐AR selective antagonist ICI 118551 caused marked rightward shifts of CR curves to isoprenaline (pK B=10.2±0.2 and 9.6±0.3), zinterol (pK B=9.0±0.1 and 9.4±0.3) and BRL 37344 (pK B=9.4±0.3 and 8.4±.2), indicating participation of β 2‐ARs. The pharmacological analysis was supported by reverse transcription and polymerase chain reaction analysis of L6 mRNA, which showed high levels of expression of β 2‐AR but not β 1‐ or β 3‐AR in these cells. Forskolin and dibutyryl cyclic AMP produced negligible increases in GT while the phosphatidylinositol‐3 kinase inhibitor, wortmannin, significantly decreased both insulin‐ and zinterol‐stimulated GT, suggesting a possible interaction between the insulin and β 2‐AR pathways. This study demonstrates that β 2‐ARs mediate the increase in GT in L6 cells to β‐AR agonists, including the β 3‐AR selective agonist BRL 37344. This effect does not appear to be directly related to increases in cyclic AMP but requires P13K. British Journal of Pharmacology (2002) 137, 9–18. doi:10.1038/sj.bjp.0704845
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Cited by
The NR4A Subgroup: Immediate Early Response Genes with Pleiotropic Physiological Roles
Maxwell, M. A., & Muscat, G. E. O. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04002 · Cited by 448
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014373 · Cited by 108
“Activation can lead to increased glucose uptake by a number of mechanisms—indirectly by vasodilation and by increasing insulin secretion from b-cells in the pancreas and directly by stimulating insulin-independent glucose uptake in skeletal muscle (Nevzorova et al., 2002, 2006).”
Self-citationAdrenergic receptors and metabolism: role in development of cardiovascular disease
Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B., & Iaccarino, G. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00265 · Cited by 89
“Indeed, acute treatment of myocytes in vitro or skeletal muscle ex vivo with β2 agonists induces a significant increase in glucose uptake, reaching comparable levels to insulin stimulation (Nevzorova et al., 2002, 2006; Ngala et al., 2008).”
Roman, E. A. F. R., Reis, D., Romanatto, T., Maimoni, D., Ferreira, E. A., Santos, G. A., Torsoni, A. S., Velloso, L. A., & Torsoni, M. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.007 · Cited by 71
Characterization of Monocarboxylate Transport in Human Kidney HK-2 Cells
Wang, Q., Lu, Y., Yuan, M., Darling, I. M., Repasky, E. A., & Morris, M. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060037b · Cited by 49
The metabolic effects of mirabegron are mediated primarily by β3‐adrenoceptors
Dehvari, N., Sato, M., Bokhari, M. H., Kalinovich, A., Ham, S., Gao, J., Nguyen, H. T. M., Whiting, L., Mukaida, S., Merlin, J., et al. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.643 · Cited by 18
Self-citation
Metadata
- Authors
- Nevzorova, J., Bengtsson, T., Evans, B. A., & Summers, R. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-09
- Volume
- 137
- Issue
- 1
- Pages
- 9-18
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2065811593
- Cited by
- 72
- References
- 1
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.